Replies to post #418939 on Anavex Life Sciences Corp (AVXL)

[gbrown6332]

"Based on the safety profile of ANAVEX®2-73 (blarcamesine), as well as clinical evidence that the study drug will continue to benefit patients."

Good point.

There are a number of world-wide Rett focused organizations and networks whose members include physicians, caregivers and parents who support Rett patients. Todays hopeful Anavex 2-73 message will spread quickly, with urgency, throughout those communities.